Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | BTN3A1 | O00481 | 6/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.39 |
| ▸ | SQLE | Q14534 | 6/20 | 0.38 |
| ▸ | ICMT | O60725 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1301155 | 1.00 | TSHR (0.65) | TSHRBTN3A1KMT2AALOX15MAPT | |
| SCHEMBL10986684 | 1.00 | TSHR (0.65) | TSHRBTN3A1KMT2AALOX15MAPT | |
| SCHEMBL28583634 | 0.96 | TSHR (0.61) | TSHRBTN3A1KMT2AALOX15MAPT | |
| SCHEMBL23576229 | 0.96 | TSHR (0.61) | TSHRBTN3A1KMT2AALOX15MAPT | |
| SCHEMBL21936846 | 0.83 | TSHR (0.65) | TSHRKMT2AALOX15MAPTMEN1 | |
| SCHEMBL7174933 | 0.83 | TSHR (0.65) | TSHRKMT2AALOX15MAPTMEN1 | |
| SCHEMBL83306 | 0.81 | TSHR (0.83) | TSHRKMT2AALOX15MAPTMEN1 | |
| SCHEMBL11360694 | 0.81 | TSHR (0.83) | TSHRKMT2AALOX15MAPTMEN1 | |
| SCHEMBL21371425 | 0.81 | TSHR (0.63) | TSHRKMT2AALOX15MAPTMEN1 | |
| SCHEMBL16820318 | 0.81 | TSHR (0.83) | TSHRKMT2AALOX15MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| EP-4526411-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| CN-119403907-A | Fragrance composition and product for delivering positive emotion | 西姆莱斯有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| WO-2023222753-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | 0903608 B C LTD (CA) | 2026-03-19 | — | — | US | disclosed |
| EP-4709160-A1 | STABLE OIL-IN-WATER MICROEMULSION COMPOSITIONS | S.C. Johnson & Son, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-20260060244-A1 | WATER-BASED PEST CONTROL COMPOSITIONS | JOHNSON & SON INC S C (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250386821-A1 | POWDER-BASED PEST CONTROL COMPOSITIONS | JOHNSON & SON INC S C (US) | 2025-12-25 | — | — | US | disclosed |
| US-12501898-B2 | Synergistic pesticidal compositions and methods for delivery of active ingredients | 0903608 B.C. LTD. (CA) | 2025-12-23 | — | — | US | disclosed |
| US-12446586-B2 | Oil-based insecticidal and insect repellent compositions | S. C. JOHNSON & SON, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | disclosed |
| WO-2010076316-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2010-07-08 | — | — | WO | disclosed |
| EP-0020058-B1 | TOTAL SYNTHESIS OF (1RS, 4SR, 5RS)-4-(4,8-DIMETHYL-5-HYDROXY-7-NONENYL)-4-METHYL-3,8-DIOXABICYCLO (3.2.1) OCTANE-1-ACETIC ACID, AND INTERMEDIATES | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-09-12 | — | — | EP | disclosed |
| EP-0020058-A1 | Total synthesis of (1RS, 4SR, 5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo (3.2.1) octane-1-acetic acid, and intermediates | ORTHO PHARMACEUTICAL CORPORATION (US) | 1980-12-10 | — | — | EP | disclosed |
| US-4237054-A | Total synthesis of (1RS,4SR,5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1] octane-1-acetic acid | ORTHO PHARMACEUTICAL CORPORATION (US) | 1980-12-02 | — | — | US | disclosed |
| US-4222937-A | Total synthesis of the utero-evacuant substance D,L-zoapatanol | ORTHO PHARMACEUTICAL CORP. (US) | 1980-09-16 | — | — | US | disclosed |
| US-4221717-A | Total synthesis of the utero-evacuant substance D,L-zoapatanol | ORTHO PHARMACEUTICAL CORPORATION (US) | 1980-09-09 | — | — | US | disclosed |
| US-4182717-A | Total synthesis of the utero-evacuant substance d,l-zoapatanol | ORTHO PHARMACEUTICAL CORP. (US) | 1980-01-08 | — | — | US | disclosed |
| US-4177194-A | Total synthesis of the utero-evacuant substance D,L-zoapatanol | ORTHO PHARMACEUTICAL CORPORATION (US) | 1979-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | TACR3, GSTO1, TIAL1 | TSHR 390/4885BTN3A1 3024/4885KMT2A 2389/4885 |
| US-20250386821-A1 | POWDER-BASED PEST CONTROL COMPOSITIONS | CLK3, MERTK, SYMPK | TSHR 4039/4885BTN3A1 3301/4885KMT2A 3320/4885 |
| US-20260060244-A1 | WATER-BASED PEST CONTROL COMPOSITIONS | SGMS2, TGFBR2, SGMS1 | TSHR 1441/4885BTN3A1 1757/4885KMT2A 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.